å ¥é¢æ²»çããå°åãžïŒPOCTãéããŠèšºæãšæ²»çãå é
éå»10幎éãç¹ã«èŸ²æå°åãäœæåŸå°åãçºå±éäžåœã«ãããŠãå»çã®åæ£åãäžççã«é²ã¿ãŸãã[1]ã忣åãã«ã¹ã±ã¢ã«ãããæš©éãäžå€®éæš©çãªæš©åãããå»çãµãŒãã¹ãŠãŒã¶ãŒã«è¿ãé åã«ã·ããããŸãããã€ã³ããªãã±ã¢æ€æ»(POCT)ããŸãã¯æ£è ã®ããããµã€ããŸãã¯ãã®è¿ãã§ã®æ€æ»ã¯ã忣åãã«ã¹ã±ã¢ã¢ãã«ã«ãããŠæçšã§ããã倧éœåžä»¥å€ã«äœãæ£è ã®ã¢ã¯ã»ã¹ã®å¢å ãè¿ éãªèšºææ±ºå®ãå¯èœã«ããè¿ éãªããããµã€ãçµæãããã³æ£è ã®æç€ºãšæ²»çãšã®éã®é å»¶æéã®æžå°ãªã©ã®å©ç¹ãæããŸãã忣åãã«ã¹ã±ã¢ã¢ãã«ã«åããäžçã®å°åã®äžäŸãã€ã³ãã§ããåœã®è³æºã¯äžåçã«åé ãããŠããŸãã倧éœåžã®äžå¿éšã¯äžå€®æ€æ»æ©é¢ãåããå é²çãªç é¢ãç¹åŸŽã§ãããã蟲æéšïŒ14å人ã®äœæ°ã®å€§åãå ãã[2]ïŒã®äººã ã¯ãããããè³æºãå ¥æããããšãéãããŠããŸããPOCTã¯ãã®ã®ã£ãããåããããšãã§ããããé éå°ã®äººã ã«ãæ£è ã±ã¢ã®çŸå Žã§ã®è¿ éãªèšºæãå¯èœã«ããæºåž¯åããŒã«ãæäŸããŸããæ©æã®çŸæ£æ€åºã®æ¹åã¯ãæ²»çãå éããç£èŠãæ¹åãã玹ä»ãæ¹åããããšãã§ããããã«ãããå»çã³ã¹ããšãšãã«å ¥é¢åã³å ¥é¢æéãççž®ããããšãã§ããŸãã POCT空éã«ãããæè¡é²æ©ïŒãã€ã¯ãæµäœ 1980幎代ã«ç»å Žãããã€ã¯ãæµäœæè¡ã¯ã埮å°ãªå å§ãã£ãã«ãéããŠå°éã®æµäœïŒãã€ã¯ããªããã«èŠæš¡ïŒãåŠçããŸãããã®æè¡ã®çšéã¯ãã€ã³ã¯ãžã§ããåã³3Då°å·ããè¬çåŠè©Šéšåã³æ°Žè³ªè©Šéšã«åã¶è€æ°ã®ç£æ¥ã«åã³ãŸããPOCTã§ã¯ããã€ã¯ãæµäœã¯ãåäžè©Šéšè£ 眮ïŒäŸãã°ãCOVID-19詊éšïŒäžŠã³ã«åäžã®æµäœè©Šæã䜿çšããŠè€æ°ã®æ€æ»å®€æ©èœãå®è¡ããããšãã§ãããã©ããªã³ããããè£ çœ®ã«ãããŠäœ¿çšãããŸãããã€ã¯ãæµäœããŒã¹ã®ã·ã¹ãã ã®å©ç¹ã«ã¯ããã€ã¯ããªããã«èŠæš¡ã®æµäœãåŠçããèœåãè¿ éãªå€é詊éšã®ããã®æ£ç¢ºãªæµäœå¶åŸ¡ãããã³è€æ°ã®POCTã·ã¹ãã ãžã®äŸåã®äœæžãå«ãŸããŸããDiscover Chemistry [3]ã«æ²èŒããã2025幎3æã®è«æã«ãããšããã€ã¯ãæµäœããŒã¹ã®POCTã·ã¹ãã ã¯ãäœãªãœãŒã¹ç°å¢ã§ã®èšºæçšéã«ããªãã®å°æ¥æ§ããããŸããããŒã¿ãã«ãã€ã¯ãæµäœè£ 眮ã¯ãäžå€®æ€æ»å®€ãžã®ã¢ã¯ã»ã¹ãå¶éãããŠãããµãŒãã¹ãäžååãªå°åã«ãããŠæ©æçŸæ£èšºæãææã«å¢å ãããããšãã§ããŸã[3]ãCOVID-19ã®ãã³ãããã¯ã«ãããPOCTã®å°å ¥ãå éããããšãããç¹ã«ææ¥å»çã®çŸå Žã§ã¯ãçŸæ£ç®¡çãæšé²ããäžã§è¿ éãã€é«æåºŠã®ãŠã€ã«ã¹æ€åºãéèŠã§ããããšãæµ®ã圫ãã«ãªããŸããã å ¥é¢æ²»çã«ãããPOCTã®äœ¿çš POCTã¯é·ãéãææ¥ç§(ED)ãéäžæ²»ç宀(ICU)ãªã©ã®éçã±ã¢ç é¢ã®ç¶æ³ã§å®çªã§ãããè¿ éãªèšºæãšæ©ææ²»çãéœæ§æ£è ã®è»¢åž°ã«éèŠã§ããéçæ£è ã¯ãèžçãçºç±ãæ¯åããªã©ã®éå¥äžèœãªçç¶ãåããããšãå€ãããã®ãããªå Žåã«ã¿ã€ã ãªãŒãªæ²»çãè¡ãããã«ã¯ãè¿ éãã€æ£ç¢ºãªèšºæãåŸãããšã極ããŠéèŠã§ãããããã®èšå®ã«ãããPOCTã®ããã®éžæãããçšéã«ã¯ãå¿èãã€ãªããŒã«ãŒãççæ§ãã€ãªããŒã«ãŒãåã³è¡æ¶²åŠçãã€ãªããŒã«ãŒã®åæãå«ãŸããããããã¯ä»¥äžã«ãã詳现ã«èšèŒãããŸãã埪ç°åšãã€ãªããŒã«ãŒPOCTã§åæããã埪ç°åšãã€ãªããŒã«ãŒã«ã¯ãããããã³Tããã³Næ«ç«¯ããBåãããªãŠã å©å°¿ãããã(NT-proBNP)ããããŸããç¡äœçºåé¢ç¯è©Šéšã«ãããŠãç ç©¶è ãã¯ãäœãªã¹ã¯æ£è ãåå®ããéSTäžæåæ¥æ§å çå矀ãé€å€ããããã«å ¥é¢åã®ç¶æ³ã§ããããã³T POCTã䜿çšããããšã«ãããäž»èŠãªæå®³å¿èã€ãã³ãã®çºççãäœãã30æ¥éã®å»çè²»ãåæžããããšçµè«ä»ããŸãããããããã³T POCTã¯ç é¢å€åã³å ¥é¢åã®ç°å¢ã§å®æœã§ããã®ã§ãäžèŠãªEDæ¥é¢ãæžããããšãã§ããŸãããã®å©ç¹ã«ã¯ãã³ã¹ãã®åæžã䞊ã³ã«æ£è ã®èŒžéã®æå°ååã³é¢é£ããäžå¿«æãå«ãŸããŸã[4]ãPOC-HFã®ãã€ããã詊éšã§ã¯ãé£ç¶çãªãã€ã³ããªãã±ã¢ã®NT-proBNP枬å®å€ããæ¥æ§é代忧å¿äžå šæ£è ã®æ²»ç決å®ã«åœ±é¿ãäžãããã©ãããæ€èšããŸãããç ç©¶è ãã¯ããã®æž¬å®å€ããçç¶ã«åºã¥ãæ²»çãšæ¯èŒããŠãè¬å€ã®æŒžå¢ã®è¿ éåãNT-proBNPã®äœäžã®é¡èããå埩ã®è¿ éåã«é¢é£ããŠããå¯èœæ§ããããšçµè«ä»ããŸãã[5]ãççæ§ãã€ãªããŒã«ãŒPOCTæè¡ã§æž¬å®ããåŸãççæ§ãã€ãªããŒã«ãŒã«ã¯ãCåå¿æ§ã¿ã³ãã¯è³ª(CRP)åã³ããã«ã«ã·ããã³(PCT)ãå«ãŸããŸããCRPã¬ãã«ã®äžæã¯éç¯€ãªææåã³ä»ã®ççç¶æ ã瀺ãåŸãã®ã§ãPOCTãä»ããŠæ£è ã®ããããµã€ãã§è€æ°ã®CRP枬å®ãè¡ãããšã¯ãæ£è ã®å¥åº·ãæ²»çã«ããæ¹åããŠãããã©ãããæ±ºå®ããéèŠã§ã¿ã€ã ãªãŒãªææ®µãæäŸããŸããPCTæ€æ»ã¯ãŠã€ã«ã¹ææã«åå¿ããŠäžæããããšã¯ãŸãã§ãããããæææºãç¹å®ããäžå¿ èŠãªæèè¬ã®äœ¿çšãé¿ããã®ã«æçšã§ãã现èè¬å€èæ§ãäžççã«å¢å ããŠããçŸåšããã®ããšã¯ç¹ã«éèŠã§ããPOCTã«ãã£ãŠæäŸãããã¿ã€ã ãªãŒãªçµæã¯ãæäŸè ãé©åãªæ²»çãè¿ éã«éå§ããããšãå¯èœã«ããŸããããã€ãã®ãã€ã³ããªãã±ã¢PCT詊éšã¯åå®éçæ°ç¯å²ãšããŠçµæãæäŸãããããå®éçæž¬å®ãçãæéæ å ã§å©çšã§ããªãå Žåã詊éšã¯ç¹ã«äŸ¡å€ãããåŸãŸã[6]ãä»å¹Ž4æã«ã ã³ãã€ã§éå¬ãããPOCTå°éå®¶ããã«ã§ãWockhardt Hospitalsã®ã¯ãªãã£ã«ã«ã±ã¢éšé·Kedar Toraskarå»åž«ã¯ãå¿çæ¢å¡ã®æ¢åŸãšãæ¥æ§èžéšéæãåŒåžå°é£ãäœè¡å§ãäœé žçŽ çã䌎ã巊宀é§åºç(LVEF)ã®äœäžãæãã66æ³ã®ç·æ§ã®çäŸã玹ä»ããŸãããèšåºæèŠãããå¿åæ§ã·ã§ãã¯åã³æè¡çæ§ã·ã§ãã¯ã®æ··åã瀺åãããŸããããã€ã³ããªãã±ã¢è¶ 鳿³¢æ€æ»(POCUS)ã§èºçåã³èºæ°Žè «ãæããã«ãªããå¿é»å³ã§åæ¹STäœäžãæããã«ãªãããšã§ãæ¥æ§å¿çã¹ãã¬ã€ã³ã®ãšããã³ã¹ãåŸãããŸãããèããCRPé«å€ã䌎ããæè¡çã«ããæ¥æ§å çå矀ã®äºéç çã瀺åãããŸããã蚺æã¯ãæ£è ãæè¡ç管çã«å ããŠè¡ç®¡åœ¢æè¡ã«ããè¿äœLADã¹ãã³ãç眮è¡ãå¿ èŠãšããå Žåã«ç¢ºèªãããŸãããPOCTã®äœ¿çšã¯ãäžå€®ç 究宀ããã®å¹é€å ±åãåŸãããåã§ãã£ãŠããæè¡çã®æ©æèšºæã«åœ¹ç«ã¡ãŸããCRPæ€æ»ã®æé ãªäŸ¡æ Œãšè¿ éãªæ§è³ªã«ãããKedar Toraskarå»åž«ãšã¢ãžã¢å€ªå¹³æŽå°åã®å°éå®¶ã¯ãåå¿ã®åŸåã確ç«ããã¿ã€ã ãªãŒãªæçç©è³ªæŒžæžãå°ãããã«ç¶ç¶çãªæ¯æ¥ã®ã¢ãã¿ãªã³ã°ã«åŸäºããããšãã§ããŸãããæ¬çäŸã®çäŸã¯ã倧åèå ãã«ãŒã³ãã³ãç眮åã³è¡ç®¡åœ¢æè¡ãæœè¡ãããŠãããèšåºçãªæ¹åã瀺ãCRPã®åŸåã«è£ä»ããããŠãæèè¬ã®æäžã驿ã«äžæ¢ããããšãã§ããŸãããPOCTãšPOCUSã®äœµçšã¯ãæªååã·ã§ãã¯ãšäœé žçŽ è¡çã®è©äŸ¡ã«éåžžã«æçšã§ãããè¿ éãã€æ£ç¢ºãªããããµã€ãã§ã®èšåºçæææ±ºå®ãå¯èœã«ããŸãã[7]ãè¡æ¶²åŠçãã€ãªããŒã«ãŒPOCTã§æž¬å®ã§ããè¡æ¶²åŠçãã€ãªããŒã«ãŒã«ã¯ããã¢ã°ããã³ããã³ããããã³ãã³ïŒåœéæšæºåæ¯ãŸãã¯PT-INRãšããŠç€ºãããçµæã䌎ãïŒãªã©ããããŸããç¹å®ã®äžçã®å°åã§ã¯ããã¢ã°ããã³ã®äœå€ãå¥åº·äžã®å€§ããªæžå¿µäºé ã§ããã€ã³ãã§ã¯ãæ¯äœè²§è¡ãèå ããã³æ°çå ã®äžè¯è»¢åž°ã®äž»ãªåå ã§ããã€ã³ãã«ãããè²§è¡ã®æç çã¯ã幎霢ãå°åãããã³æ§å¥ã«ãã£ãŠå€§ããç°ãªããŸããäŸãã°ãã€ã³ãã«ãããç·æ§ã®è²§è¡ã®æç çã¯çŽ25%ã§ããã®ã«å¯ŸããŠã女æ§ã§ã¯57%ã6ã«æãã5æ³ã®åã©ãã§ã¯67%ã§ã[8]ãè²§è¡ã«å¯ŸããPOCTã®å©ç¹ã«ã¯ãæ¯çްè¡ç®¡è¡ã®äœ¿çšïŒéèåéãŸãã¯æ€æ»ã¹ã¿ããã®ããªãå»çç°å¢ãå«ãããã«ã¢ããªã±ãŒã·ã§ã³ãæ¡å€§ïŒãè¿ éãªçµæïŒåæ¥æ²»çã®éå§ãå¯èœã«ããïŒãããã³ããã€ã¹ã®æºè¡æ§ïŒç°èããã³äœã€ã³ãã©ç°å¢ã§åäœãããã³ããã«ãã®ããããªãŒé§åã¢ãã©ã€ã¶ã䜿çšããïŒãå«ãŸããŸã[9]ããããã®å©ç¹ã¯ã蚺æãäžååãªéå£ã«è¿ã¥ãããã©ããŒã¢ããã®æå€±ãæžãããŸãã忣åã±ã¢ã«ãããPOCTã®äœ¿çšPOCTã¯äŒçµ±çã«ç é¢ã®ã¯ãªãã£ã«ã«ã±ã¢ç°å¢ã§äººæ°ããããŸãããããã®æè¡ã®äŸ¡å€ã¯ãåšå® ã±ã¢ãä»£æ¿æœèšã±ã¢ãé éå°ãäœæåŸå°åã忣åãã«ã¹ã±ã¢ã®åŒ·åãªæ¡çšãããå°åãªã©ãä»ã®ç°å¢ã§ãåºã蚎ããããŠããŸãããããã«ãæ°åã³ãããŠã£ã«ã¹ (COVID-19) ã®ãã³ãããã¯ã¯ãé éå»çãç é¢ä»¥å€ã§ã®è¿ éãªæ€æ»ãžã®é¢å¿ãé«ããŸãããæ¬ã·ã¹ãã ã¯ãå»çå¶åºŠãšå»çåŸäºè ãããŠäžè¬ã®æ¹ã ã«ãšã£ãŠæçã§ãã忣åã«ãããå»çã·ã¹ãã ã¯ãã±ã¢ã管çããéèŠãªãµãŒãã¹ã«çŠç¹ãåœãŠããŠãŒã¶ã®ããã®æšæºåããããã¬ãŒãã³ã°ããã°ã©ã ã宿œããããã®è²»çšå¯Ÿå¹æã®é«ãæ¹æ³ã§å»çè²»ã®å¢å ã«å¯Ÿå¿ããããšãã§ããŸããå»çæ©é¢ã®å Žåã忣åã«ããæ£è äžå¿ã®ã±ã¢ãå¯èœã«ãªããå ¥é¢æéãççž®ãããå°éãµãŒãã¹ã«éç¹ã眮ãããããã«ãªããŸããæ£è ã®æºè¶³åºŠã¯ã忣åã±ã¢ã®åºç€ã§ãããæ£è ã®ããŒãºãžã®å¯Ÿå¿ã®å¢å ããµãŒãã¹æäŸã®æ¹åãæšé²ããŸã[1]ãæ£è ã®ããŒãºãæºããéèŠãªæ¹æ³ã¯ãé éå°ãè³éäžè¶³ã®å°åã«ãããå»çãµãŒãã¹ãžã®ã¢ã¯ã»ã¹ãæäŸããããšã§ãã POCTã¯ã蚺æãšæ²»çã®ãªãŒããæ¡å€§ããã ãã§ãªããæ²»çãŸã§ã®æéãå€§å¹ ã«ççž®ã§ããã¿ã€ã ãªãŒãªæ¹æ³ã§è¡ãããã®éèŠãªããŒã«ãšãªãå¯èœæ§ããããŸããããã«ãã€ã³ãã®å»çç°å¢ã«ã¯ãèªå·±è² æ ã®æ¯åºã®ããªãã®å²åãå«ãŸããŠããŸãïŒç·å»çæ¯åºã®ã»ãŒååãå ããïŒ [10]ãéœåžéšã«ç¹åãããµãŒãã¹ãéäžãããšãã¢ã¯ã»ã¹ãæžå°ããå€ãã®å Žåãæ è¡ãå®¿æ³æœèšã®è¿œå è²»çšãè² æ ããããåŸãŸãã[11]ãPOCTã¯ããããã®è¿œå ã³ã¹ãã軜æžãããšåæã«ãæ²»çæéã®ççž®ãå¯èœã«ãããã€ã³ããªãã±ã¢æè¡ã®æ¡çšãä¿é²ããããšãã§ããŸããã€ã³ããªã©ã®åæ£åå»çã®æ¡çšãå€ã人å£å¯åºŠã®é«ãäžçå°åã§ã¯ãPOCTã䜿çšããŠæ©æã®èšºæãšä»å ¥ãå¯èœã«ããããšã§ãç³å°¿ç ãªã©ã®æ ¢æ§çŸæ£ã®ç®¡çã«å€§ããªåœ±é¿ãäžããå¯èœæ§ããããŸããåœéç³å°¿ç é£å(International Diabetes Federation)ã«ãããšã2024幎ã®ã€ã³ãã«ãããç³å°¿ç ã®æç çã¯20ïœ79æ³ã®æäººã§8980äžäººïŒå¹Žéœ¢æšæºåæç ç10.5%ïŒã§ããã2050幎ã«ã¯ããã1å5,670äžäººã«å¢å ãããšäºæž¬ãããŠããŸã[12]ãPOCTã¯ãéäžæ€æ»ãªãœãŒã¹ãžã®ã¢ã¯ã»ã¹ãå¶éãããŠããé éå°åã«èšºæèœåãæäŸããèœåãæã£ãŠããŸã[3]ããã®æè¡ã¯ãçŸæ£ãè¿ éã«åºå¥ããè¿ éãªä¿¡é Œæ§ã®é«ãçµæãšæ²»çæéã®ççž®ãæ£è ã«æäŸããèœåãæããŠããŸãã以äžã®ã±ãŒã¹ã¹ã¿ãã£ãåç §ããŠãã ãããç³å°¿ç ã®çäŸç ç©¶POCTæ²»çã«é¢ããåè¿°ã®å°éå®¶ããã«ã§ãDr Vishal Chopra Diabetes and Thyroid Careã®åµèšè ã§ããDr Vishal Chopraã¯ãæ¯åããèŠåœèé害ãé žéèå§ã®äžæãé塿§ç¡ç æç¡åŒåžçå矀ã®çããæãã54æ³ã®ç·æ§ã®çäŸã匷調ããŸãããæ£è ã®ç æŽã«ã¯ã2åç³å°¿ç ãé«è¡å§ãç²ç¶è ºæ©èœäœäžçããã³è¥æºã®èšºæãå«ãŸããŠããŸãããç³å°¿ç æ£è ã«å¯ŸããåŸæ¥ã®æ€æ»ã«ã¯ãã°ã«ã³ãŒã¹ããã³HbA1cã®æ€æ»ãå«ãŸããããPOCTã·ã¹ãã ã§å©çšå¯èœãªè€æ°ã®ã¢ãã»ã€ã«ãããèšåºå»ã¯CRPããã³NT-proBNPãå«ãè€æ°ã®ãã©ã¡ãŒã¿ãæ€æ»ããããšãã§ããŸãããããè³æ§ãããªãŠã å©å°¿ããããåé§äœN端ãã©ã°ã¡ã³ã(NT-proBNP)å€ãäžæããå¿å䜵çãèªããããã®ã«å¯ŸããCRPå€ã®äžæã¯ççæ§ãããã¯æææ§ã®åºç€çŸæ£ã瀺åããŸããã巊宀é§åºç(LVEF)ã®ä¿ãããå¿äžå šãšãå°¿è·¯ææã«ããæ¥æ§è é害ãèªããŸããããã®ããã«è€éãªèšåºåãšç³å°¿ç ã®æ¢åŸæŽã®ãããå¿çŸæ£ã®åå®ãé ããå¯èœæ§ã¯ãããŸããããPOCTãçšããããšã§æ©æã®èšºæãšä»å ¥ãå¯èœãšãªããé倧ãªäºè±¡ãé²ãããšãã§ããŸãã[13]ã ãšãã¹ããŒãã€ã³ãµã€ã å°éå®¶ã¯ãç çå»ã埮çç©åŠè ãªã©ã®èšç·Žãåããå°éå®¶ã«ããæ€æ»å®€è©Šéšçµæã®æ€èšŒã®å¿ èŠæ§ã匷調ããŠããŸãããPOCTã·ã¹ãã ã®è©äŸ¡ã¯è¯å®çã§ãããå€ãã®ç é¢ããã³éç é¢ã®ç¶æ³ã§å©çãæããã§ããPOCTã«é¢é£ããèšåºçæçšæ§ã®å©ç¹ã¯ããã®æè¡ããæéã¯ãªãã£ã«ã«ãªèšåºçµè·¯ãŸãã¯éäžæ€æ»å®€ã€ã³ãã©ã¹ãã©ã¯ãã£ãžã®ã¢ã¯ã»ã¹ãå¶éããããªã¢ãŒãããã³ãªãœãŒã¹å¶éã®ããç°å¢ã«ãããŠããšããã³ã¹ã«åºã¥ãè¿ éãªæ±ºå®ãå¯èœã«ããããšã§ããPOCTã®äž»ãªéçšäžã®å©ç¹ã¯ãæè¡çãå¿çæ¢å¡ãªã©ã®ç·æ¥äºæ ã®ã·ããªãªã§æ¥µããŠéèŠãªãè¿ éãªæèŠæéã§ãã忣åã®ç°å¢ã§ã¯ãæ£è ã®åŸ ã¡æéãççž®ããçŸå Žã«ããéã«ãã©ããŒã¢ãããšæ²»çã®ããã«æ£è ããã£ããã£ã§ããããšããPOCTã®éèŠãªã¡ãªããã§ããããã¯ãç¹ã«ç³å°¿ç ãªã©ã®æ ¢æ§çŸæ£ã®ã¹ã¯ãªãŒãã³ã°ãŸãã¯èšºæã«é©çšãããŸããããã«ããã©ã€ããªã±ã¢ç°å¢ã«æ¥é¢ããŠããç·æ¥ç¶æ ã®æ£è ã¯ãPOCTã䜿çšããŠè©äŸ¡ããããšãã§ãããã©ã€ããªã±ã¢æäŸè ãæ£è ã®æ£ç¢ºãªããªã¢ãŒãžæ±ºå®ïŒçŸå Žã§æ£è ãæ²»çãããããããªãä»å ¥ã®ããã«ç é¢ã«éãïŒãè¡ããããã«ããŸãã çµè« POCTã¯ãçŸæ£ãè¿ éã«èšºæããã¿ã€ã ãªãŒãªä»å ¥ãå¯èœã«ããããã®æºåž¯åã®å€çšéãªæè¡ãæäŸããæ£è ã®è»¢åž°ãå€§å¹ ã«æ¹åããå¯èœæ§ãæããŸããããã¯ãèšºææ€æ»å®€ãåããé«åºŠãªç é¢ãžã®ã¢ã¯ã»ã¹ãå¶éãããå¯èœæ§ã®ããå°åã§ç¹ã«åœãŠã¯ãŸããŸãããã ããå€§èŠæš¡ãªç é¢ç°å¢ã§ãã£ãŠããPOCTã¯ãã»ãšãã©ã®å Žåãäžå€®æ€æ»å®€ãããçãæèŠæéãæäŸããã¿ã€ã ãªãŒãªæ²»çã«ã€ãªããå¯èœæ§ããããŸããäžççã«åæ£åå»çã®äººæ°ãé«ãŸãã«ã€ããPOCTã¯å»çã¢ã¯ã»ã¹ãæ¹åããããã®éèŠãªããŒã«ã§ããç¶ããç é¢ãã¯ãªããã¯ãããã³ã³ãã¥ããã£ç°å¢ã§è€æ°ã®ãŠãŒã¹ã±ãŒã¹ãçºçããŠããŸããæè¡ã®ç¶ç¶çãªé²åãšå©çšå¯èœãªã¢ãã»ã€ã®æ¡å€§ã¯ã蚺æãããã«æ°äž»åããããå€ãã®æ€æ»ãæ£è ã«è¿ã¥ããã±ã¢æäŸãå€é©ããããšãçŽæããŸãã åèæç® [1] Becker’s Hospital Review (2024) An essential strategy for the future of healthcare: decentralization.以äžããå ¥æïŒ https://www.beckershospitalreview.com/strategy/an-essential-strategy-for-the-future-of-healthcare-decentralization/ ïŒã¢ã¯ã»ã¹ïŒ2025幎9æ7æ¥ïŒ [2] Statista (2025) ã€ã³ãã®èŸ²æéšãšéœåžéšã®äººå£ã以äžããå ¥æïŒ https://www.statista.com/statistics/621507/rural-and-urban-population-india/ ïŒã¢ã¯ã»ã¹ïŒ2025幎9æ30æ¥ïŒ [3] Das,A.and […]
å ¥é¢æ²»çããå°åãžïŒPOCTãéããŠèšºæãšæ²»çãå é Read More »




